ArticleBMJ open2020

Assessing the safety and feasibility of neoadjuvant hormone and radiation therapy followed by robot-assisted radical prostatectomy for treating locally advanced prostate cancer: protocol for an open-label, dose-escalation, single-centre, phase I clinical trial.

Yu-Tian Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.